EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Structural variant and nucleosome occupancy dynamics postchemotherapy in a HER2+ breast cancer organoid model

Maja Starostecka iD, Hyobin Jeong iD, Patrick Hasenfeld, Eva Benito-Garagorri, Tania Christiansen, Catherine Stober Brasseur, Maise Gomes Queiroz iD, Marta Garcia Montero iD, Martin Jechlinger, Jan O Korbel

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2415475122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Maja Starostecka und 9 weiteren Autor:innen. Beteiligte Einrichtung: European Molecular Biology Laboratory, Genome Biology Unit, Heidelberg 69117, Germany. Hauptthemen laut MEDLINE: Nucleosomes, Organoids, Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: EC | ERC | HORIZON EUROPE European Research Council (ERC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The most common chemotherapeutics induce DNA damage to eradicate cancer cells, yet defective DNA repair can propagate mutations, instigating therapy resistance and secondary malignancies. Structural variants (SVs), arising from copy-number-imbalanced and -balanced DNA rearrangements, are a major driver of tumor evolution, yet understudied posttherapy. Here, we adapted single-cell template-strand sequencing (Strand-seq) to a HER2+ breast cancer model to investigate the formation of doxorubicin-induced de novo SVs. We coupled this approach with nucleosome occupancy (NO) measurements obtained from the same single cell to enable simultaneous SV detection and cell-type classification. Using organoids from TetO-CMYC/TetO-Neu/MMTV-rtTA mice modeling HER2+ breast cancer, we generated 459 Strand-seq libraries spanning various tumorigenesis stages, identifying a 7.4-fold increase in large chromosomal alterations post-doxorubicin. Complex DNA rearrangements, deletions, and duplications were prevalent across basal, luminal progenitor (LP), and mature luminal (ML) cells, indicating uniform susceptibility of these cell types to SV formation. Doxorubicin further elevated sister chromatid exchanges (SCEs), indicative of genomic stress persisting posttreatment. Altered nucleosome occupancy levels on distinct cancer-related genes further underscore the broad genomic impact of doxorubicin. The organoid-based system for single-cell multiomics established in this study paves the way for unraveling the most important therapy-associated SV mutational signatures, enabling systematic studies of the effect of therapy on cancer evolution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NucleosomesOrganoidsBreast NeoplasmsErb-b2 Receptor Tyrosine KinasesFemaleDoxorubicinAnimalsHumansMiceDNA Copy Number Variations

Stichwörter der Autor:innen

breast cancerorganoidssingle-cell multi-omicsstructural variation

Substanzen

NucleosomesDoxorubicinErb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • European Molecular Biology Laboratory, Genome Biology Unit, Heidelberg 69117, Germany.
  • Faculty of Biosciences, Collaboration for joint PhD degree between European Molecular Biology Laboratory and Heidelberg University, Heidelberg 69120, Germany.
  • Department of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Republic of Korea.
  • Bridging Research Division on Mechanisms of Genomic Variation and Data Science, German Cancer Research Center, Heidelberg 69120, Germany.
  • European Molecular Biology Laboratory, Cell Biology and Biophysics Unit, Heidelberg 69117, Germany.
  • Molecular and Information Technology Institute for Personalized Medicine gGmbH, Heilbronn 74076, Germany.

ORCID-Profile: Maja Starostecka, Hyobin Jeong, Maise Gomes Queiroz, Marta Garcia Montero

Förderung

  • EC | ERC | HORIZON EUROPE European Research Council (ERC)

Zitieren

APA

Starostecka, M., Jeong, H., Hasenfeld, P., Benito-Garagorri, E., Christiansen, T., Stober Brasseur, C., Gomes Queiroz, M., Garcia Montero, M., Jechlinger, M., & Korbel, J. O. (2025). Structural variant and nucleosome occupancy dynamics postchemotherapy in a HER2+ breast cancer organoid model. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2415475122

Vancouver

Starostecka M, Jeong H, Hasenfeld P, Benito-Garagorri E, Christiansen T, Stober Brasseur C, et al. Structural variant and nucleosome occupancy dynamics postchemotherapy in a HER2+ breast cancer organoid model. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2415475122

BibTeX
@article{Starostecka2025,
  author = {Starostecka, Maja and Jeong, Hyobin and Hasenfeld, Patrick and Benito-Garagorri, Eva and Christiansen, Tania and Stober Brasseur, Catherine and Gomes Queiroz, Maise and Garcia Montero, Marta and Jechlinger, Martin and Korbel, Jan O},
  title = {Structural variant and nucleosome occupancy dynamics postchemotherapy in a HER2+ breast cancer organoid model},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2415475122}
}
Kostenlos starten →